|
1
|
Sharma P, Mahadevia H, Donepudi S, Kujtan
L, Gustafson B, Ponvilawan B, Al-Obaidi A, Subramanian J and Bansal
D: A novel EGFR germline mutation in lung adenocarcinoma: Case
report and literature review. Clin Lung Cancer. 25:479–482. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sun R, Hou Z, Zhang Y and Jiang B: Drug
resistance mechanisms and progress in the treatment of EGFR-mutated
lung adenocarcinoma. Oncol Lett. 24:4082022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li N and Zhan X: Identification of
pathology-specific regulators of m(6)A RNA modification to optimize
lung cancer management in the context of predictive, preventive,
and personalized medicine. EPMA J. 11:485–504. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shu J, Jiang J and Zhao G: Identification
of novel gene signature for lung adenocarcinoma by machine learning
to predict immunotherapy and prognosis. Front Immunol.
14:11778472023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liu A, Wang Z, Yang Y, Wang J, Dai X, Wang
L, Lu Y and Xue F: Preoperative diagnosis of malignant pulmonary
nodules in lung cancer screening with a radiomics nomogram. Cancer
Commun (Lond). 40:16–24. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prosper AE, Kammer MN, Maldonado F, Aberle
DR and Hsu W: Expanding role of advanced image analysis in
CT-detected indeterminate pulmonary nodules and early lung cancer
characterization. Radiology. 309:e2229042023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma L, Qiu B, Zhang J, Li QW, Wang B, Zhang
XH, Qiang MY, Chen ZL, Guo SP and Liu H: Survival and prognostic
factors of non-small cell lung cancer patients with postoperative
locoregional recurrence treated with radical radiotherapy. Chin J
Cancer. 36:932017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hirsch FR, Scagliotti GV, Mulshine JL,
Kwon R, Curran Jr WJ, Wu YL and Paz-Ares L: Lung cancer: Current
therapies and new targeted treatments. Lancet. 389:299–311. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hajipour S, Hosseini SM, Irani S and
Tavallaie M: Identification of novel potential drugs and miRNAs
biomarkers in lung cancer based on gene co-expression network
analysis. Genomics Inform. 21:e382023. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma H, Jiang S, Yuan Y, Li J, Li Y, Lv Y,
Du T, Guan J, Jiang X, Tian L, et al: RUNX1 promotes proliferation
and migration in non-small cell lung cancer cell lines via the mTOR
pathway. FASEB J. 37:e231952023. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jiang J, Zhang Y, Wang J, Yang X, Ren X,
Huang H, Wang J, Lu J, Zhong Y, Lin Z, et al: Identification of
CDT1 as a prognostic marker in human lung adenocarcinoma using
bioinformatics approaches. Peer J. 11:e161662023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gong L, Zhang D, Dong Y, Lei Y, Qian Y,
Tan X, Han S and Wang J: Integrated bioinformatics analysis for
identificating the therapeutic targets of aspirin in small cell
lung cancer. J Biomed Inform. 88:20–28. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang H, Peng Y and Guo Y: Pulmonary
nodules detection based on multi-scale attention networks. Sci Rep.
12:14662022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kossenkov AV, Qureshi R, Dawany NB,
Wickramasinghe J, Liu Q, Majumdar RS, Chang C, Widura S, Kumar T,
Horng WH, et al: A gene expression classifier from whole blood
distinguishes benign from malignant lung nodules detected by
low-dose CT. Cancer Res. 79:263–273. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wei L, Wu Y, Cai S, Qin Y, Xing S and Wang
Z: Long non-coding RNA linc01224 regulates hypopharyngeal squamous
cell carcinoma growth through interactions with miR-485-5p and
IGF2BP3. J Cancer. 14:3009–3022. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song S, Xie S, Liu X, Li S, Wang L, Jiang
X and Lu D: miR-3200 accelerates the growth of liver cancer cells
by enhancing Rab7A. Noncoding RNA Res. 8:675–685. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lai C, He N, Zeng J, Long C, Shi M, Li J,
Ma S, Xiong Y and Liang X: Highly expressed miR-144-3p promotes the
proliferation, migration and invasion of colon carcinoma cells by
activating the Wnt/beta-catenin signaling pathway through targeting
SFRP1. J Cancer. 14:3117–3129. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang D, Zhang S, Zhao M and Chen F: LncRNA
MALAT1 accelerates non-small cell lung cancer progression via
regulating miR-185-5p/MDM4 axis. Cancer Med. 9:9138–9149. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Y, Hu Y, Wu Y, Zhang D and Huang D:
LINC00205 promotes tumor malignancy of lung adenocarcinoma through
sponging miR-185-5p. Lab Med. 53:39–46. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yu N, Gong H, Chen W and Peng W: CircRNA
ZKSCAN1 promotes lung adenocarcinoma progression by
miR-185-5p/TAGLN2 axis. Thorac Cancer. 14:1467–1476. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rehbein G, Simm A, Hofmann HS, Silber RE
and Bartling B: Molecular regulation of S100P in human lung
adenocarcinomas. Int J Mol Med. 22:69–77. 2008.PubMed/NCBI
|
|
23
|
Tan BS, Yang MC, Singh S, Chou YC, Chen
HY, Wang MY, Wang YC and Chen RH: LncRNA NORAD is repressed by the
YAP pathway and suppresses lung and breast cancer metastasis by
sequestering S100P. Oncogene. 38:5612–5626. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hsu YL, Hung JY, Liang YY, Lin YS, Tsai
MJ, Chou SH, Lu CY and Kuo PL: S100P interacts with integrin alpha7
and increases cancer cell migration and invasion in lung cancer.
Oncotarget. 6:29585–29598. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chien MH, Lee WJ, Hsieh FK, Li CF, Cheng
TY, Wang MY, Chen JS, Chow JM, Jan YH, Hsiao M, et al: Keap1-Nrf2
interaction suppresses cell motility in lung adenocarcinomas by
targeting the s100p protein. Clin Cancer Res. 21:4719–4732. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wu T, Chen Y, Yang L, Wang X, Chen K and
Xu D: Ribonuclease a family member 2 promotes the malignant
progression of glioma through the PI3K/Akt signaling pathway. Front
Oncol. 12:9210832022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma J, Bai Y, Chen F, Zhou F, Zhang L, Xue
P and Wang D: MicroRNA-185-5p targets tyrosine
3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta
to regulate non-small cell lung cancer progression. J Cardiothorac
Surg. 18:2412023. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wen H, Liu Z, Tang J and Bu L: MiR-185-5p
targets RAB35 gene to regulate tumor cell-derived exosomes-mediated
proliferation, migration and invasion of non-small cell lung cancer
cells. Aging (Albany NY). 13:21435–21450. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li H, Han D, Hou Y, Chen H and Chen Z:
Statistical inference methods for two crossing survival curves: A
comparison of methods. PLoS One. 10:e01167742015. View Article : Google Scholar : PubMed/NCBI
|
